
Oxford Immunotec Global PLC Market Cap 2011-2026 | OXFD
As of May 24, 2026 Oxford Immunotec Global PLC has a market cap of $ 562 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Oxford Immunotec Global PLC
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | 421 M | 369 M | 279 M | 295 M | 253 M | 204 M | 78.8 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 421 M | 78.8 M | 271 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Castle Biosciences
CSTL
|
472 M | $ 20.15 | -1.9 % | $ 584 M | ||
|
Centogene N.V.
CNTG
|
221 M | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B | ||
|
Guardant Health
GH
|
13.4 B | $ 118.95 | 0.8 % | $ 14.9 B | ||
|
Fulgent Genetics
FLGT
|
527 M | $ 17.11 | -1.55 % | $ 517 M | ||
|
ICON Public Limited Company
ICLR
|
16.6 B | $ 116.78 | 0.18 % | $ 9.63 B | ||
|
Agilent Technologies
A
|
42 B | $ 114.96 | 0.15 % | $ 34.9 B | ||
|
Celcuity
CELC
|
5.37 B | $ 138.23 | -3.02 % | $ 6.46 B | ||
|
Co-Diagnostics
CODX
|
5.85 M | $ 5.07 | 36.66 % | $ 6.74 M | ||
|
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
3.03 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
4.03 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
993 M | $ 21.63 | 0.28 % | $ 1.15 B | ||
|
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
4.33 M | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
16.4 B | $ 144.41 | -0.29 % | $ 23 B | ||
|
Interpace Biosciences
IDXG
|
7.34 M | $ 1.82 | 1.11 % | $ 8.05 M | ||
|
Lantheus Holdings
LNTH
|
5.12 B | $ 103.0 | 9.03 % | $ 6.95 B | ||
|
Medpace Holdings
MEDP
|
13 B | $ 432.8 | 0.63 % | $ 12.5 B | ||
|
Global Cord Blood Corporation
CO
|
304 M | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
28.4 B | $ 1 103.09 | 1.16 % | $ 22.7 B | ||
|
Fluidigm Corporation
FLDM
|
481 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
133 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.54 B | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
7.69 B | $ 160.3 | 0.91 % | $ 7.95 B | ||
|
Personalis
PSNL
|
431 M | $ 8.47 | 2.67 % | $ 756 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
7.87 B | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
57.5 K | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
1.48 B | $ 9.23 | 1.32 % | $ 1.18 B | ||
|
Exact Sciences Corporation
EXAS
|
19.5 B | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
315 M | $ 19.08 | 0.21 % | $ 427 M | ||
|
Natera
NTRA
|
5.31 B | $ 203.19 | -0.25 % | $ 20 B | ||
|
Myriad Genetics
MYGN
|
409 M | $ 3.82 | -2.3 % | $ 354 M | ||
|
Koninklijke Philips N.V.
PHG
|
30.3 B | $ 26.95 | -0.74 % | $ 25.6 B | ||
|
Senseonics Holdings
SENS
|
351 M | $ 6.34 | 2.92 % | $ 265 M | ||
|
QIAGEN N.V.
QGEN
|
8.52 B | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
1.56 B | $ 60.57 | 2.95 % | $ 3.62 B | ||
|
Soleno Therapeutics
SLNO
|
2.08 B | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
7.19 M | $ 2.49 | 2.05 % | $ 5.72 M | ||
|
Laboratory Corporation of America Holdings
LH
|
23.9 B | $ 259.93 | 1.63 % | $ 21.6 B | ||
|
Thermo Fisher Scientific
TMO
|
196 B | $ 448.28 | -0.24 % | $ 169 B | ||
|
Trinity Biotech plc
TRIB
|
194 M | $ 0.6 | -3.7 % | $ 216 M | ||
|
Motus GI Holdings
MOTS
|
990 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
1.02 B | $ 8.9 | 0.45 % | $ 1.93 B | ||
|
Waters Corporation
WAT
|
19.7 B | $ 342.37 | 0.4 % | $ 20.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
23.3 B | $ 195.21 | 0.72 % | $ 21.7 B |